14.0
Regeneron Pharmaceuticals, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
billions USD
FY21:
FY22:
15.9
FY23:
19.5
FY24:
18.7
FY25:
18.0
(positive)
Change from FY21 to FY25
billions USD
FY21:
11.4
FY22:
13.3
FY23:
13.6
FY24:
19.1
FY25:
22.5
Total assets
Change from FY21 to FY25
billions USD
FY21:
25.4
FY22:
29.2
FY23:
33.1
FY24:
37.8
FY25:
40.6
Liabilities & Equity
(negative)
Change from FY21 to FY25
billions USD
FY21:
3.93
FY22:
3.14
FY23:
3.42
FY24:
3.94
FY25:
4.37
(negative)
Change from FY21 to FY25
billions USD
FY21:
2.73
FY22:
3.41
FY23:
3.68
FY24:
4.46
FY25:
4.93
(positive)
Change from FY21 to FY25
billions USD
FY21:
18.8
FY22:
22.7
FY23:
26.0
FY24:
29.4
FY25:
31.3
Total liabilities & equity
Change from FY21 to FY25
billions USD
FY21:
25.4
FY22:
29.2
FY23:
33.1
FY24:
37.8
FY25:
40.6
All amounts in billions USD